Acetazolamide EP Impurity C

Basic Information

View in Editor

CAS Number

32873-56-6

Molecular Formula

C4H5N3OS2

Molecular Weight

175.24 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Water Treatment Chemicals Coagulants and Flocculants Inorganic Coagulants

Basic Physical Properties

Melting Point

293-298°C

SMILES

View in Editor

CC(=O)NC1=NNC(=S)S1

InChI

InChI=1S/C4H5N3OS2/c1-2(8)5-3-6-7-4(9)10-3/h1H3,(H,7,9)(H,5,6,8)

InChIKey

DWSMAMSVZRCQMP-UHFFFAOYSA-N

LogP

0.7851999999999997

Topological Polar Surface Area

54.88 Å²

Hydrogen Bond Donor/Acceptor

1 / 4

Complexity

213

Safety Information

View Safety Information

Hazard Statement

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

Acetazolamide Impurity C
AKOS000297161
AM803704
N-(5-Thioxo-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide
6B8475348K
{N}-(5-mercapto-1,3,4-thiadiazol-2-yl)acetamide
PD186955
F0326-0071
BCP33861
NSC97893
ACETAZOLAMIDE IMPURITY C [EP IMPURITY]
N-(5-mercapto-1,3,4-thiadiazol-2-yl)acetamide
MFCD00128160
MLS002703417
AC-5578
5-Acetamido-2-thiol-1,3,4-thiadiazole
FT-0639064
N-(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)acetamide
N-(5-Sulfanyl-1,3,4-thiadiazol-2-yl)acetamide, AldrichCPR
AS-10839
SMR001570136
N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide
2-Acetamido-5-mercapto-1,3,4-Thiadiazole
2-Acetylamino-5-mercapto-1,3,4-thiadiazole
C4H5N3OS2
Z235488576
acetamide, N-(5-mercapto-1,3,4-thiadiazol-2-yl)-
SY171932
EN300-26971
A821479
W10680

MDL Number

MFCD00128160

Customs Code

2934999090

FAQ

What regulatory guidelines apply to Acetazolamide EP Impurity C (CAS: 32873-56-6)?

Acetazolamide EP Impurity C (CAS: 32873-56-6) is subject to regulatory guidelines such as GHS classification, REACH regulations, and FDA/EPA requirements. GHS classification involves hazard communication including physical and health hazards. REACH regulations require manufacturers and importers to register chemical substances. FDA and EPA have specific guidelines for the handling and disposal of pharmaceutical impurities, including documentation and reporting requirements.

Are there alternatives to Acetazolamide EP Impurity C (CAS: 32873-56-6) in synthesis?

In the synthesis of acetazolamide, alternatives to Acetazolamide EP Impurity C (CAS: 32873-56-6) may include other azole derivatives or isomers. Commonly, synthetic routes may use different reagents such as acetamide or sulfuric acid. It is important to evaluate the purity and chemical properties of the alternatives to ensure they meet the desired specifications for the final product.

What is the market or research trend for Acetazolamide EP Impurity C (CAS: 32873-56-6)?

The market for Acetazolamide EP Impurity C (CAS: 32873-56-6) is closely tied to the development and production of acetazolamide for medical use. Research trends focus on optimizing synthetic processes to reduce impurities and improve drug efficacy. Market trends show a steady demand for pharmaceutical intermediates, with a growing emphasis on quality and safety in drug manufacturing processes.

How should waste containing Acetazolamide EP Impurity C (CAS: 32873-56-6) be handled?

Waste containing Acetazolamide EP Impurity C (CAS: 32873-56-6) should be handled according to local regulations and safety guidelines. Waste liquid collection should be done in sealed containers, followed by professional incineration or chemical waste disposal methods. Environmental protection measures include ensuring that disposal processes comply with GHS and REACH regulations. Proper documentation and reporting of waste management activities are also essential.